UCB SpA in Motion 2023

Moving towards improved outcomes in PsA

SpA in Motion is a UCB initiative, designed to share knowledge and educate rheumatologists about spondyloarthritis.

During this event our chairs will provide a highly scientific program, presented by international key opinion leaders and has a focus on Psoriatic Arthritis.

We are looking forward to welcome you to the 2024 symposium.

REGISTER NOW

Time and Date:

March 21^st 2024
18:30 - 20:45 CET

Location:

virtually via our interactive online platform
and via local hubs (subject to local availability)

Chairs:

Dr Sofia Ramiro
Rheumatologist and Senior Researcher
at Leiden University Medical Center and
Zuyderland Medical Center, The Netherlands

Lars Erik Kristensen
Professor and Head of Research
at the Parker Institute in Copenhagen,
Denmark

AGENDA

18.30 CET
Welcome from the chairs

Dr Sofia Ramiro, Rheumatologist and a Senior Researcher at Leiden University Medical Center and Zuyderland Medical Center, The Netherlands
Professor Lars Erik Kristensen, Rheumatologist and Head of Research at the Parker Institute in Copenhagen, Denmark

18.35 CET
Early PsA including early diagnosis and risk factors; Including Polls and Discussion

Alen Zabotti MD, Central Friuli University Health Authority (ASU FC) - Santa Maria della Misericordia University Hospital (Department of Specialized Medicine - Rheumatology Clinic) Italy

19.15 CET
PsA, updated guidelines and how does the treatment landscape look like? How does the evidence translate into practice? ; Including Polls and Discussion

Prof Laure Gossec MD PhD, Public Assistance-Hospitals of Paris (AP-HP) - Pitié-Salpêtrière University Hospital (Rheumatology Service - Rheumatology Unit) France

19.55 CET
Challenges in clinical practice/management – practice to evidence; Including polls and Discussion

Prof Daniel Aletaha, MD, MS, MBA, head of the Division of Rheumatology at the Medical University Vienna, Austria

20.35 CET
Summary and closing statement

Dr Sofia Ramiro and Professor Lars Erik Kristensen

20.45 CET
End of Meeting

REGISTRATION

First name*

Last name*

Clinic/Hospital*

Clinic/Hospital Email*

Postal code*

I have read and understood UCB's General Privacy Policy for healthcare professionals (UGPPH), accessible here. *

We will process your personal data in accordance with the UGPPH. The UGPPH informs you on the why and how UCB processes your personal data, your rights as a data subject (including your right of access, rectification and objection to direct marketing and, in certain circumstances, a right of erasure, portability and a right to object to non-marketing related processing or to restrict the processing of your data) and how to contact us.

I consent to receiving communications from UCB S.A. and its affiliates on UCB products, services, company news, as well as on medical and scientific information pertaining to my areas of interest, using the contact details I provide. This also includes invitations to UCB hosted webinars, CME events and surveys.

You can unsubscribe at any time by clicking the unsubscribe link included in future email communications sent to you by UCB.

These educational live events are initiated and funded by UCB Pharma and its affiliates. Date of preparation: December 2023 | AT-DA-2300035

Hoge Mosten 2
4822 NH Breda
The Netherlands

For Danish participants:

Arrangementet er/vil blive anmeldt til ENLI, inden arrangementets afholdelse og er efter UCB Nordics opfattelse i overensstemmelse med reglerne på området, selv om arrangementet ikke på forhånd er godkendt af ENLI.

For Norwegian participants:

Dette arrangementet arrangeres i samsvar med avtaler om samhandling som Legemiddelindustriforeningen har inngått med Den norske legeforening, Norges Farmaceutiske Forening, Norsk Sykepleierforbund og De regionale helseforetakene. For deg som helsepersonell medfører dette at både du og arrangøren har rettigheter og plikter som skal sikre at arrangementet er av god faglig kvalitet og at det ikke er egnet til å skape forestillinger om uheldige bindinger mellom industri og helsepersonell. For mer informasjon se LMIs nettsider.

For Swedish participants:

Den enskilde medarbetaren ansvarar för att inhämta godkännande från huvudman. Inbjudan skickas med kopia till huvudman. Arrangemanget genomförs i samarbete med UCB Pharma AB, enligt gällande avtal mellan LIF och SKR. Deltagande i mötet kräver godkännande från klinikchef/verksamhetschef enligt gällande avtal mellan LIF och SKR. Försändelsen är utsänd med stöd av uppgifter ur Hälso- och Sjukvårdens Adressregister, HSAR, av UCB Nordic A/S, som är ansluten till Integritetsskyddsprogrammet för HSAR. Ytterligare information om adressuppgifter och registrering erhålls via http://www.hsar.se/ eller av Cegedim AB, 08-6337680.